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Background: Meta-analyses are typically triggered by a (potentially false-significant) finding in one of the preceding
primary studies. We studied consequences of meta-analysis investigating effects when primary studies that triggered such
meta-analysis are also included.
Methods: We analytically determined the bias of the treatment effect estimates obtained by meta-analysis, conditional
on the number of included primary and false-significant studies. The type I error rate and power of the meta-analysis were
assessed using simulations. We applied a method for bias-correction, by subtracting an analytically derived bias from the
treatment effect estimated in meta-analysis.
Results: Bias in meta-analytical effects and type I error rates increased when increasing numbers of primary studies with
false-significant effects were included. When 20% of the primary studies showed false-significant effects, the bias was 0.33
(z-score) instead of 0, and the type I error rate was 23% instead of 5%. After applying a bias-correction, the type I error rate
became indeed 5%.
Conclusions: Inclusion of primary studies with false-significant effects leads to biased effect estimates and inflated type I
error rates in the meta-analysis, depending on the number of false-significant studies. This bias can be adjusted for.
Keywords: Meta-analysis, Bias, Type I error, PowerBackground
Meta-analysis, either using aggregate or individual par-
ticipant data, involves the synthesis of results or data
from several studies and is considered the best design to
determine the effects of particular exposures or inter-
ventions [1,2]. Meta-analyses do not stand alone; they
are often the final analysis of a period of accumulating
scientific evidence, either investigating main effects or
differential effects of the intervention across subgroups
(subgroup effect).
Initially, primary studies are designed to show an over-
all effect of the treatment on the main or primary out-
come. Those studies are often too small (underpowered)
to be able to detect subgroup effects or adverse out-
comes. Therefore, it makes sense to combine the infor-
mation obtained from multiple studies, by conducting a* Correspondence: eschuit@stanford.edu
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unless otherwise stated.meta-analysis, since the statistical power of a meta-
analysis will be higher than those of the individual stud-
ies. The choice to initiate a meta-analysis may be based
on an observed effect or trend towards an effect in a sin-
gle study. Obviously, such an effect may be falsely sig-
nificant [3]. As such, these effects, that is, main effects
in small trials but also subgroup effects or effects in ad-
verse outcomes for which the primary study was not de-
signed, may in fact be spurious findings [3-6], yet they
may trigger the conduct of a meta-analysis. Conse-
quently, meta-analysis including these studies is more
prone to bias [7-12].
Previously, Pereira and Ioannidis found that most
meta-analyses with significant findings pertain to truly
non-null-effects, but that exceptions are not uncommon
(that is, more common than the expected 5%) [5]. Their
study was based on published meta-analyses, obtained
from the Cochrane Database of Systematic Reviews, but
did not investigate the consequences for the meta-
analysis when the trigger study (potentially false-
significant) is included in the meta-analysis and howThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of the meta-analysis) could be solved.
Therefore, our aim was to specifically discuss the implica-
tion of conducting a meta-analysis that was triggered by re-
sults of one or more primary study effects that are also
included in that meta-analysis. Throughout the following,
we will use the term effect, to indicate a certain treatment
effect, which can be either a main effect, subgroup effect, or
unintended effect. We stress, however, that a trigger for a
meta-analysis will often be a significant finding of a sub-
group effect in one of the included studies, rather than the
main effect. First, we will derive analytically what the im-
pact is of the inclusion of primary studies with false-
significant results in a meta-analysis on the bias in the effect
estimate from the meta-analysis. Then, using simulations,
we will assess the impact of this conduct on the type I error
rate (that is, rate of false-significant studies) and the power
(that is, rate of true-significant studies) of meta-analysis.
Moreover, we suggest a simple correction method to adjust
for potentially inflated type I error rates and bias, using the




In meta-analysis, effect estimates from individual studies
are pooled. These estimates can relate to main effects, sub-
group effects, effects within subgroups, or unintended ef-
fects. As indicated above, throughout this paper, we will use
the term effect, to indicate a certain treatment effect, which
can be either of these effects.
Suppose that five trials have been conducted in which ef-
fects of a certain treatment were assessed. Then, under the
assumption of a null-effect, any non-significant study in-
cluded in the meta-analysis is correctly non-significant,
whereas significant ones are false-significant. By chance,
one of the five trials may show a false-significant association
between treatment and outcome. Since the results of the
five trials are inconsistent, this finding may lead to the con-
duct of a meta-analysis in order to pool all available infor-
mation to obtain a final answer to the question about the
effects of the treatment.
The overall estimate obtained in a meta-analysis usu-
ally is a weighted average of the effect estimates of the
individual studies, both significant and non-significant,
included in the meta-analysis. An overall effect estimate








With wi as the weight that represents the contribution
of study i, which is equal to the inverse of the within
study variance (for a fixed effects model), or equal to theinverse of the within and between study variance τ2 (for
a random effects model), and Êi as the effect estimate in
study i.
If studies included in a meta-analysis have approxi-
mately the same size and overall the treatment has no ef-
fect, the combined effect of the non-significant studies will
be relatively close to zero, since those studies did not show
a significant effect. In contrast, the combined effect of the
false-significant (under the assumption of a null-effect)
studies will be relatively far from zero. Suppose, a treat-
ment under study has no effect on the outcome, yet a
meta-analysis was triggered by a false-significant result in
one study while there were five studies included in total.
In that case, the overall estimate in the meta-analysis is a
weighted average of an effect that is far from zero (one
false-significant study) and four effects that are close to
zero (four non-significant studies): the estimate in the
meta-analysis then likely differs from zero. Obviously, the
deviation from zero depends on both the effect estimate in
each primary study and the sample size of those studies.
Since the true treatment effect is zero, the estimate of the
meta-analysis is a biased estimate of the true treatment ef-
fect. On average, in the case of endless repetition of meta-
analyses (some including significant studies, others not),
one still expects to observe a treatment effect of zero, that
is, no bias.
Analytical derivation of bias
In order to analytically determine the magnitude of the bias
of the treatment effect obtained in the meta-analysis, we
consider a continuous outcome and the treatment effect is
defined as the difference of the mean outcome value of the
two treatment groups (A and B). In the following, we as-
sume that the true treatment effect equals zero.
The amount of bias in the effect estimate in the meta-
analysis is defined as the average difference between the es-
timated effect in the meta-analysis (Equation 1) and the
true treatment effect. In the case of no effect, the mean
effect of a meta-analysis is expected to be zero, and the
test-statistic of the effect follows a z-distribution. The effect
estimate obtained from a meta-analysis is a weighted aver-
age of the effects from the included studies, which include
both significant and non-significant studies. In the signifi-
cant studies, the effect should exceed a certain value, in
order to achieve significance. Similarly, in the non-
significant studies, the effect will not exceed this value.
Based on a known boundary of significance (for example,
0.05 significance level), and under the assumption of a null-
effect, the expected means of the significant and non-
significant studies can be derived from a truncated normal
distribution (Figure 1) [14]. In the case of a standard nor-
mal distribution and a one-sided test at a 0.05 significance
level, the significant effects will lie in the rejection region of
a normal distribution that is truncated at a z-score of 1.65,
Figure 1 Truncated standard normal distribution. The overall mean of E, Ē, is zero. Truncation at E = e splits up the distribution into a rejection region and
non-rejection region. These regions have an expected mean of E[Ê] and E[Ê’], respectively [14]. For e = 1.65, E[Ê'] = −0.108 and E[Ê] = 2.07.
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rejection region of that truncated normal distribution. The
expected mean effects of the non-significant studies (E[Ê’])
and the significant studies (E[Ê]) can be calculated as de-
scribed by Barr and Sherrill [14] and are under a null-effect
approximately equal to −0.108 and 2.07, respectively, for a
one-sided significance level of 0.05. Suppose that under a
null-effect, a meta-analysis was based on the significant re-
sults in one study (that is, false-significant) while there are
five studies included in total, then the overall effect estimate
obtained by meta-analysis is expected to be (4 * (−0.108) +
1 * (2.07)) / 5 = 0.33. Notice that this overall expectation of
the effect estimate differs from zero and is thus biased since
the true effect was zero. In the case of a two-sided statistical
test, two significant studies may have opposite effects which
may cancel out. Therefore, the above approach is only ap-
plicable to a one-sided test. We do acknowledge that most
meta-analyses apply two-sided statistical tests and we come
back to this issue in the discussion of this paper.
Apart from the mean effects of the significant and
non-significant studies, the size of this bias depends on
the number of small and large studies, which are signifi-
cant or non-significant. Under a null-effect, the effect es-
timate is equal to the bias and can, under a fixed effects
approach, be derived from Equation 1 (Additional file 1):
effect ¼ nssNs þ nlsNlð Þ⋅2:07þ nsnsNs þ nlnsNlð Þ⋅−0:108
nssNs þ nlsNl þ nsnsNs þ nlnsNl
ð2Þ
With nsns as the number of non-significant small stud-
ies, nlns as the number of non-significant large studies,
nss as the number of significant small studies, nls as the
number of significant large studies, Ns as the sample size
of the small studies, Nl as the sample size of the large
studies, −1.08 as the expected mean difference between
treatments A and B in the non-significant studies, and
2.07 as the expected mean difference between treatments A
and B in the significant studies (that is, 2.07 for a one-sided
0.05 significance level).Simulation studies of statistical inference in meta-analysis
Simulation set-up
We set up a simulation study to assess the performance of
statistical analysis in meta-analysis, that is, the type I error
rate (that is, rate of incorrect rejection of the null-
hypothesis) and power (rate of correct rejection of the
null-hypothesis). We considered a continuous outcome,
measured in individuals allocated to treatments A and B.
To evaluate type I error rates, we simulated a zero effect
while we simulated a difference to evaluate power. Under
the assumption of a difference in effect of 0.2 between
treatments A and B, a variance of 1, a desired power of
80%, and a type I error rate of 5%, approximately 330 indi-
viduals were needed in each treatment arm of the meta-
analysis. The individuals were divided over 10 studies, with
the proportion of small studies in the meta-analysis vary-
ing from 10% to 80% and the ratio of the sample sizes in
the small and large studies ranging from larger studies that
had a sample size that was equal, or 2, 4, or 8 times larger
than that of the small studies (Table 1). Note that since
the sample size was calculated based on the overall meta-
analysis, all individual studies had a power of less than
80%. These sample sizes were used in both scenarios.
For each scenario, we determined the number of small
studies and the ratio in sample size between small and large
studies. Then, within each simulation, we simulated con-
tinuous outcomes for all individuals included in the meta-
analysis (either assigned to treatment A or treatment B). To
assess the type I error rates, the continuous outcome of in-
dividuals allocated to treatments A or B was drawn from a
standard normal distribution (that is, mean 0, variance 1)
to simulate a true zero effect. In the second scenario, to
simulate a non-zero effect, we simulated a 0.2 difference in
the continuous outcome between treatments A and B, by
sampling outcomes from a standard normal distribution for
treatment A and from a normal distribution with a mean
0.2 and a variance 1 for treatment B. Then, based on the
number of small studies and the ratio between the sample
size of the small and large studies, the simulated individuals
were distributed over the ten individual studies.





Sample size per study per arm for different ratios of














1 5 40 9 36 17 34
2 5 40 10 40 18 36
3 6 48 11 44 19 38
4 6 48 12 48 21 42
5 7 56 13 52 22 44
6 9 72 15 60 24 48
7 11 88 17 68 25 50
8 14 112 21 82 28 56
All scenarios were simulated 1,000,000 times and were used to assess the type
I error rate and the power of the overall meta-analysis using both a fixed and
a random effects models. To assess the type I error rate, a zero effect was simulated
using a standard normal distribution (mean 0, variance 1) for both treatment arms.
To assess the power, a treatment effect of 0.2 was simulated using a standard
normal distribution for treatment A and a normal distribution (mean 0.2,
variance 1) for treatment B. aAll meta-analyses combined roughly 330 individuals
per treatment arm (numbers may deviate due to rounding off).
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mean outcome value between treatments A and B) and
its significance (based on a one-sided two-sample t-test)
were estimated in each individual study. Next, the study
level results of the ten studies were combined. and the
mean effect estimate and its significance were estimated
on the meta-analysis level using a fixed as well as a ran-
dom effects model. Effect estimates from individual
studies were weighted by the inverse of the variance
within studies in a fixed effects approach and by the in-
verse of the variance within and between (τ2) studies in
the random effects approach [13]. The type I error rate
was estimated by the mean number of false-significant
meta-analyses (simulated a zero effect), while the power
was estimated as the mean number of true-significant
meta-analyses (simulated a true effect).
To assess the type I error rate and the power, simula-
tion were performed 1,000,000 times. Such a large num-
ber was needed to assess the type I error rate (scenario
1) and power (scenario 2) in a situation that, for ex-
ample, four studies showed a false-significant result. Say
that ten studies are simulated under a null-effect, then
the chance that three out of these ten studies are false-
significant is 0.053 * 0.957 * 10 = 0.00087. Therefore, to
be able to draw conditional conclusions (for example, if
three studies showed a false-significant result), such
large numbers of simulation runs were needed. The
large number of simulations resulted in a standard error
of the type I error rate of 0.0002179449 in the case of
three false-significant studies in a meta-analysis of tenstudies. Hence, averaged type I error rates have a 95%
probability of being in the range of 4.96 to 5.04% if the
true type I error rate was indeed 5%. The standard error
of the power was 0.0004, that is, averaged power has a
95% probability of being in the range of 79.93 to 80.07%,
if the true power was indeed 80%.
Bias-correction
A possible solution to correct for a potentially inflated
type I error rate and inadequate power is to apply a
bias-correction based on the analytical bias, which was
derived above. To evaluate this approach, we subtracted
the analytical bias (calculated using Equation 2) from the
effect estimate in the meta-analyses, thereby correcting
for the sample size of the individual studies by multiply-
ing the bias by 4Ni , where Ni indicates the sample size of
a study (either small or large). Next, we determined the
type I error rate and power again using this corrected
estimate. All statistical analyses were conducted using R
for Windows, version 2.15.2 [15].
Results
Bias in meta-analysis
Application of Equation 2 (that is, under the assumption
of no difference in the mean outcome value between
treatments A and B) showed that the bias in the overall
effect obtained in the meta-analysis increased with an in-
creasing number of false-significant studies included in
the meta-analysis (Figure 2). When none of the total ten
studies showed a false-significant result, the bias was
negative, while a positive bias was found when one or
more studies had a false-significant result. The upper
bound of the bias was found when all of the significant
studies were large (that is, none of the small studies
showed a false-significant effect), while the lower bound
of the bias was found when all false-significant studies
were small (that is, none of the small studies showed a
false-significant effect). For other combinations, for ex-
ample, one large false-significant study and an increasing
number of false-significant small studies, the bias of the
effect estimate from the meta-analysis was found to be
in-between the extremes (data not shown).
Simulation studies of statistical inference in meta-analysis
The results of the simulation study with no difference be-
tween treatments A and B and the use of a fixed effects
model showed that the type I error rate of the overall meta-
analysis increased when the number of studies with a false-
significant effect included in the meta-analysis increased
(Figure 3). The most extreme type I error rates were found
when only large studies were false-significant (highest)
or when only small studies included in the meta-
analysis showed a false-significant effect (lowest). Other
Figure 2 Bias in effect estimates from meta-analysis due to inclusion
of false-positive studies. The dashed horizontal line indicates the bias
over all simulated meta-analyses, which is equal to zero. The triangles
indicate the bias in relation to the number of false-significant studies
(we assumed no treatment effect) in the meta-analysis when only large
studies showed a false-significant effect. The crosses show the bias
when all false-significant studies were small.
Figure 3 Type I error rate in meta-analysis in relation to the number
of false-significant studies (we assumed no treatment effect) included in
the meta-analysis. The dashed horizontal line indicates the type I error of
all simulated meta-analyses together, which is equal to 5%. The
solid lines show the type I error rate obtained by simulation and
the dotted lines indicate the type I error rate after bias-correction.
The triangles indicate the type I error rate in relation to the number of
false-significant studies in the meta-analysis when all false-significant
studies were large. The crosses show the type I error rate when all
false-significant studies were small.
Figure 4 Power in the meta-analysis in relation to the number of
true-significant studies (we assumed a treatment effect) included in
the meta-analysis. The dashed horizontal line indicates the power of
all simulated meta-analyses together, which is equal to 80%. The triangles
indicate the power in relation to the number of true-significant studies in
the meta-analysis when all true-significant studies were large. The crosses
show the power when all true-significant studies were small.
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resulted in a type I error rate of the overall meta-analysis
that was in-between these boundaries (data not shown).
After the bias-correction, the type I error rate of the meta-
analysis was below 5%, independent of the number of
studies with a false-significant effect (Figure 3). As ex-
pected, the type I error rate was lower when using a ran-
dom effects model than seen for a fixed effects model but
was still substantial (data not shown). When only the
small studies were false-significant, the type I error rate
for a meta-analysis using a random effects model showed
to be similar to the fixed effects model, as expected.
Under a simulated treatment effect of a mean difference
of 0.2 between treatments A and B and using a fixed effects
model, the power of the meta-analysis increased when the
number of studies with a true-significant effect in the meta-
analysis increased (Figure 4). When there were no true-
significant studies included in the meta-analysis, the power
of the meta-analysis was approximately 50%. This increased
to about 70% with inclusion of one true-significant study
and approached 90% when two or more true-significant
studies were included. The extremes of the power of the
meta-analysis were found when only large studies were
true-significant (highest) or when only small studies in-
cluded in the meta-analysis showed a true-significant effect
(lowest). The bias-correction (that is, subtracting the
amount of bias under the null-hypothesis from the effect
estimate in the meta-analysis) did not affect the power of
the meta-analysis if a non-zero treatment effect was
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higher than the effect that was corrected for (0). As ex-
pected, the random effects model resulted in less power of
the meta-analysis as compared to the fixed effects model
for all possible combinations of true-significant and false-
negative small and large studies (data not shown). The
power of the overall meta-analysis was only marginally in-
fluenced by the proportion of small studies (varied from 10
to 80% of the total number of included studies) and the ra-
tio of the sample size between the small and large studies
(sample size in large studies was 2, 4 or 8 times larger than
in the small studies) in the meta-analysis (that is, similar to
solid line with circles in Figure 4).
Discussion
We showed that inclusion of primary studies with false-
significant effects in a meta-analysis may bias the effect esti-
mates from that meta-analysis. Consequently, the type I
error rates will not meet the prespecified nominal level
(usually 5%), particularly when the number of false-
significant studies included in a meta-analysis is high and
the false-significant studies are among the larger ones in-
cluded for meta-analysis. Using a simple correction based
on the number of included studies, the number of included
significant studies, and the sample sizes of the included
studies, the nominal type I error rate can be controlled
without losing power of the meta-analysis in the event of a
non-zero treatment effect.
Our simulations show that applying bias-correction is
an effective way to maintain the nominal type I error rate.
We determined this bias-correction analytically assuming
a z-distribution of the ratio of the effect estimate and its
standard error of the studies included in the meta-
analysis. Consequently, this approach for analytical bias
may be representative for other statistics that follow a
z-distribution or a chi-square distribution, such as the
log (odds ratio). Hence, the results of this study are
generally applicable, but the particular form of bias-
correction may differ.
There are several findings from our study that need
further elaboration. First, a negative bias (that is, a bias
in the direction opposite to the direction of the one-
sided alternative statistical hypothesis) was found for the
situation in which none of the included studies showed
a false-significant effect (under the assumption of no
treatment effect) (Figure 2). This is a result of applying a
one-sided test; the average effect size of the meta-
analysis is expected to be negative since none of the
effects from the included primary studies exceeded a
certain positive threshold. If a two-sided test were ap-
plied, the average effect size of a meta-analysis in which
only true negative studies (that is, correctly non-
significant) are included would be zero, because positive
as well as negative extreme effect would be excluded. Asa consequence, the magnitude of the bias due to select-
ive inclusion into a meta-analysis in the presence of an
effect cannot be derived. However, it is to be expected
that in the presence of a true positive effect, particular
studies with such a positive effect will be significant and
thus excluded from the meta-analysis resulting in a
negative bias. Likewise, in the presence of a true negative
effect, the meta-analysis will be positively biased.
Second, if there were no studies with a true-significant
effect included in the meta-analysis (that is, under the
assumption of a non-zero treatment effect), the power of
the meta-analysis was close to 50% (Figure 4), which is
substantially lower than 80%. This is remarkable because
the aim of a meta-analysis is often to combine all avail-
able primary studies, commonly including a majority of
non-significant primary studies, in order to obtain a
more precise and indeed possibly significant effect esti-
mate in the meta-analysis. When none of the individual
studies included in the meta-analysis shows a (true) sig-
nificant effect, even though the true effect is for ex-
ample, 0.2 (as in our example), the pooled effect in the
meta-analysis will consequently be lower than 0.2 be-
cause of the aforementioned negative bias. As a result,
the statistical power to detect this effect will decrease.
The distribution of standardized effect sizes (z-scores) of
adequately sized meta-analyses (adequately sized to have
a power of 80% when the type I error rate is set at 5%)
will approximately correspond to a normal distribution
of mean 2.83 and standard deviation 1. However, the dis-
tribution of standardized effect sizes in the selected
group of meta-analyses that only include non-significant
trials is shifted: mean 1.61 and standard deviation 1.
Since the mean of the latter distribution is close to a test-
statistic of 1.65 (corresponding to a one-sided significance
level of 5%), approximately half of all meta-analyses without
any significant studies will have a significant result. Hence,
the power of such a meta-analysis is close to 50%.
Third, the power of the meta-analysis could be main-
tained and was only marginally influenced after applying
our bias-correction. In our simulations, the effect esti-
mate of the meta-analysis with an increasing number of
true-significant studies will be higher than the simulated
true effect size (0.2). Therefore, subtracting the analytical
bias (based on a null-hypothesis) will still result in an
overall power of 80%.
Fourth, the type I error rates and power were lower when
applying a random effects model than using a fixed effects
meta-analytical model. This was expected since a random
effects model gives, under the simulation of fixed effects,
less efficient treatment effect estimates. In a random effects
model, the weights of the studies with a higher precision
(that is, the studies with larger sample sizes) are lower com-
pared to a fixed effects model. Consequently, the influence
of the larger studies on the effect estimates in the meta-
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ference between treatments A and B in the meta-analysis
will be lower and less often significant. This results in a
lower type I error rate as well as a lower power.
As with every simulation study, assumptions had to be
made. In this study, we focused on two scenarios of which
one simulated a treatment difference of 0.2 on a continuous
scale between both treatment arms and in which the meta-
analysis included ten studies. Additionally, in the derivation
of Equation 2 (see Additional file 1), we assumed that the
variance of the outcome to be the same over all studies, the
sample sizes in both arms to be similar over studies, and
the sample size and treatment effect were independent. Ob-
viously, results may be different for large (dichotomous)
treatment effects, larger or smaller meta-analyses, and un-
balanced treatment arms or more diverse in the sample size
of the included studies; these topics were beyond the scope
of this study.
In this study results, we performed both fixed effects
meta-analysis and random effects meta-analysis using the
method of DerSimonian and Laird, as these are the two
most often used methods in scientific literature [13].
However, especially when the number of studies is
small or when substantial differences among study esti-
mates exist, the method of DerSimonian and Laird may
produce confidence interval that are too narrow [16].
Therefore, alternative, more reliable methods could be
considered including small-sample adjustments, profile
likelihood, or hierarchical Bayesian models [16]. How-
ever, to illustrate the phenomenon that type I error
rates depend on the number of significant studies in-
cluded in a meta-analysis, we focused on more straight-
forward methods.
All analyses in this study focused on meta-analyzing a
main treatment effect. In general, false-significant main
effects are less likely than false-significant secondary,
safety, or subgroup effects, because primary studies are
in principle designed to reliably investigate a treatment
effect on the main outcome. As such, the problem of the
initiation of a meta-analysis based on a false-significant
study is more prominent in the case of meta-analysis for
secondary, safety, or subgroup effects. Therefore, re-
searchers should be especially aware of this problem in
such meta-analyses.
Conclusions
Meta-analyses are typically triggered by an effect in one
of the preceding primary studies; a finding that may be
false-significant. Inclusion of primary studies with false-
significant effects leads to biased effect estimates and in-
flated type I error rates in the meta-analysis, depending
on the number of false-significant studies. The goal in
each new study is to replicate previous findings. When
true replication of the effect is the aim, a solution tolower the bias and type I error rate would be to exclude
the study that triggered the meta-analysis. Alternatively,
this bias can be solved by endless repetition of meta-
analyses, which we consider impossible and, therefore,
the proposed bias-correction, in which the trigger study
is included in the meta-analysis, appears to be a viable
solution.Additional file
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